India covid-19 vaccine Immunic India

India gets emergency use nod for first indigenous mRNA vaccine against Covid

Reading now: 222
www.livemint.com

vaccine against Covid-19. The SEC under India's drug regulator found data submitted by Gennova Biopharmaceuticals satisfactory in Friday's meeting.

The company had submitted the data back in April and provided additional data in May. Last month, Gennova had released a statement to news agency ANI regarding updates on submitting phase 3 data. "Gennova is in communications with the regulatory agency and submitting all necessary data and information required for the product approval," said Gennova's spokesperson. "Product development using innovative technologies like mRNA, a fourth-generation vaccine platform stable at 2 to 8 degrees Celcius, is a challenging journey during pandemic times," the spokesperson further said.

The company has conducted phase 2 and phase 3 data trials on 4000 participants to evaluate vaccine safety, immunogenicity and tolerability.

The vaccine - GEMCOVAC-19 - is the country's first homegrown mRNA Covid- 19 vaccine and is seen as a game-changer for the healthcare industry. What are mRNA vaccines? Messenger RNA is a type of RNA that is necessary for protein production.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA